Not Yet RecruitingPhase 4

Opioid Sparing Effect of Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery: a Randomized Controlled Clinical Trial.

60 participantsStarted 2025-01-01

Plain-language summary

Functional endoscopic sinus surgery (FESS) is widely recognized as a safe and preferred treatment option for various conditions, particularly nasal polyps and rhinosinusitis . This technique has been shown to improve postoperative symptoms by 86.3% in patients with chronic inflammatory paranasal sinus diseases . The aim of this study is to evaluate the effect of adding of MgSO4 to bupivacaine via SPGB block for postoperative pain for 24 hours in patients scheduled for FESS as opioid free anaesthesia.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Patients programmed for elective FESS * American society of anaesthesiologists (ASA) physical state I-II * Age over 18 years and less than 60-years-old. Exclusion Criteria: * • Known hypersensitivity to the study drugs. * Inability to accurately describe postoperative pain to investigators. * Opioid tolerance or dependence. * Patient refusal * History of renal, liver, cardiac, neuropsychiatric disorder problems. * Bleeding or coagulation abnormality. * Infection at the site of injection

What they're measuring

postoperative pain according to (NRS)

Timeframe: 24 hours

Trial details

NCT IDNCT06752525

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-01

Contact for this trial

Ahmed Mohamed Ali Ismaeil, resident doctor

+20106 9071633 Ahmed.16285222@med.aun.edu.eg

View on ClinicalTrials.gov More Sinus Surgery trials